NO762464L - - Google Patents
Info
- Publication number
- NO762464L NO762464L NO762464A NO762464A NO762464L NO 762464 L NO762464 L NO 762464L NO 762464 A NO762464 A NO 762464A NO 762464 A NO762464 A NO 762464A NO 762464 L NO762464 L NO 762464L
- Authority
- NO
- Norway
- Prior art keywords
- stated
- formula
- substance
- compound
- parts
- Prior art date
Links
- 241000208125 Nicotiana Species 0.000 claims description 54
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 54
- 239000000126 substance Substances 0.000 claims description 44
- 239000000463 material Substances 0.000 claims description 34
- 229930182478 glucoside Natural products 0.000 claims description 26
- 230000000391 smoking effect Effects 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- 150000008131 glucosides Chemical class 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 150000001720 carbohydrates Chemical class 0.000 claims description 13
- 239000000779 smoke Substances 0.000 claims description 10
- -1 glycosyloxy compound Chemical class 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical group C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 claims description 6
- 150000002016 disaccharides Chemical class 0.000 claims description 5
- 125000003051 glycosyloxy group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 150000002772 monosaccharides Chemical class 0.000 claims description 5
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 claims description 4
- 229920003086 cellulose ether Polymers 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 claims description 4
- 239000012285 osmium tetroxide Substances 0.000 claims description 4
- 229910000489 osmium tetroxide Inorganic materials 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000005051 trimethylchlorosilane Substances 0.000 claims description 3
- 150000000180 1,2-diols Chemical class 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- 150000002402 hexoses Chemical class 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims 3
- 239000000446 fuel Substances 0.000 claims 2
- 150000004820 halides Chemical class 0.000 claims 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- 239000000243 solution Substances 0.000 description 30
- 229930182470 glycoside Natural products 0.000 description 26
- 150000002338 glycosides Chemical class 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 235000019504 cigarettes Nutrition 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- YYZGYGHTZBOPEE-UHFFFAOYSA-N solavetivone Natural products CC1CC(=O)C(=CC12CCC(C2)C(=C)C)C YYZGYGHTZBOPEE-UHFFFAOYSA-N 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 238000005481 NMR spectroscopy Methods 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 10
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 9
- 230000003595 spectral effect Effects 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 7
- 235000011130 ammonium sulphate Nutrition 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 235000019502 Orange oil Nutrition 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000004811 liquid chromatography Methods 0.000 description 6
- 239000010502 orange oil Substances 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 239000001095 magnesium carbonate Substances 0.000 description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 4
- 235000014380 magnesium carbonate Nutrition 0.000 description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 229940043279 diisopropylamine Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000005979 thermal decomposition reaction Methods 0.000 description 3
- JZRJXZHBHSDLDS-CYBMUJFWSA-N (3r)-6,10-dimethyl-3-prop-1-en-2-ylspiro[4.5]deca-6,9-dien-8-one Chemical compound C1[C@H](C(=C)C)CCC21C(C)=CC(=O)C=C2C JZRJXZHBHSDLDS-CYBMUJFWSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- JZRJXZHBHSDLDS-UHFFFAOYSA-N Anhydro-beta-rotunol Natural products C1C(C(=C)C)CCC21C(C)=CC(=O)C=C2C JZRJXZHBHSDLDS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- CYAYKKUWALRRPA-RGDJUOJXSA-N [(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1O[C@H](Br)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O CYAYKKUWALRRPA-RGDJUOJXSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 229910052747 lanthanoid Inorganic materials 0.000 description 2
- 150000002602 lanthanoids Chemical group 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- KFUSEUYYWQURPO-UHFFFAOYSA-N 1,2-dichloroethene Chemical compound ClC=CCl KFUSEUYYWQURPO-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- GEHMBYLTCISYNY-UHFFFAOYSA-N Ammonium sulfamate Chemical compound [NH4+].NS([O-])(=O)=O GEHMBYLTCISYNY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000002351 beta-D-glucopyranosyloxy group Chemical group 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- WACQKHWOTAEEFS-UHFFFAOYSA-N cyclohexane;ethyl acetate Chemical compound CCOC(C)=O.C1CCCCC1 WACQKHWOTAEEFS-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019695 salad leaves Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical class N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Røkemateriale, samt aromagivende middel for dette Smoking material, as well as flavoring agent for this
Oppfinnelsen vedrører substanser som er nyttige som aromastoffer, mer spesielt som røk-aromastoffer for tobakk, rekonstituert tobakk og tobakk-erstatninger, med hvilket det menes materialer som, selv om de ikke er av tobakk-opprinneIse, er røkbare på samme måte som sigaretter, sigarer, piper osv. The invention relates to substances which are useful as flavourings, more particularly as smoke flavorings for tobacco, reconstituted tobacco and tobacco substitutes, by which is meant materials which, although not of tobacco origin, are smokeable in the same way as cigarettes, cigars, pipes, etc.
Det er blitt fremsatt forslag angående erstatning av tobakk med substitutter for denne fordi tobakk-røk er kjent å være produktiv når det gjelder sykdommer i bronkiene og lungene. De kjente substitutter er, til tross for forbedrede helsekarakteristika i sammenligning med tobakk, av begrenset verdi på grunn av sin røkearoma som ikke ligner tobakk. For å gi en uttalt grad av tobakkaroma har det hittil vært nød-vendig med innblanding av store andeler av tobakk og/eller ekstrakter av tobakk, hvorved de oppnåelige sunnhetsmessige fordeler reduseres. Proposals have been made regarding the replacement of tobacco with substitutes for it because tobacco smoke is known to be productive in diseases of the bronchi and lungs. The known substitutes, despite improved health characteristics compared to tobacco, are of limited value due to their smoke aroma which does not resemble tobacco. In order to give a pronounced degree of tobacco aroma, it has hitherto been necessary to mix in large proportions of tobacco and/or extracts of tobacco, whereby the achievable health benefits are reduced.
Oppfinnelsen tilveiebringer en substans som omfatter et hydroksy- eller glykosyloksy- mono- eller di-umettet spirovetivon. The invention provides a substance comprising a hydroxy- or glycosyloxy-mono- or di-unsaturated spirovetione.
Spirovetivon har følgende formel og den nummerering som er anvendt i det følgende ved betegnelse av dets derivater som vist. Spirovetivone has the following formula and the numbering used in the following when naming its derivatives as shown.
Ovenstående formel og alle andre formler som er brukt i det følgende, er konvensjonelle, idet hver vinkel eller util-knyttet valenslinje representerer et karbonatom med alle sine fire valenser besatt, enten på den angitte måte eller på annen måte ved tilknyttede hydrogenatomer. The above formula and all other formulas used in the following are conventional, in that each angle or unattached valence line represents a carbon atom with all four of its valences occupied, either in the manner indicated or otherwise by attached hydrogen atoms.
Mer spesielt tilveiebringer oppfinnelsen en substans som omfatter en forbindelse av formelen More particularly, the invention provides a substance comprising a compound of the formula
hvor i formel I ett av radikalene og R2 e* hydrogen og det annet representerer enten en hydroksylgruppe eller en glykosyloksy-gruppe -OX hvor X er radikalet av et mono- eller disakkarid, og de stiplede linjer representerer eventuelle posisjoner for en dobbeltbinding, og i formel II representerer R| enten en hydroksylgruppe eller ovennevnte glykosyloksygruppe -OX. where in formula I one of the radicals and R2 is hydrogen and the other represents either a hydroxyl group or a glycosyloxy group -OX where X is the radical of a mono- or disaccharide, and the dashed lines represent possible positions for a double bond, and in formula II represents R| either a hydroxyl group or the above-mentioned glycosyloxy group -OX.
Substansene i henhold til oppfinnelsen er nyttige som aromastoffer, spesielt som røk-arqmastoffer for tobakk, tobakk-erstatninger og blandinger derav. The substances according to the invention are useful as aroma substances, especially as smoke aroma substances for tobacco, tobacco substitutes and mixtures thereof.
De forbindelser av formel I som inneholder en glykosyloksy-gruppe -OX er de foretrukne forbindelser. The compounds of formula I which contain a glycosyloxy group -OX are the preferred compounds.
Søkeren har identifisert glukosider av formlene I og II (hvor X representerer en glukosylgruppe) som bestanddeler i tobakk,chvor de er til stede i overordentlig små mengder. The applicant has identified glucosides of formulas I and II (where X represents a glucosyl group) as constituents of tobacco, where they are present in exceedingly small quantities.
Sterkt konsentrert preparater, inneholdende forStrongly concentrated preparations, containing for
eksempel 25 vek t% eller mer av glukbsidene, kan oppnås fra tobakk. Én fremgangsmåte for oppnåelse av slike preparater omfatter ekstrahering av tobakk med et lavtkokende ketonisk løsningsmiddel, for eksempel aceton, suksessiv fjerning frå eg 25 wt% or more of the glucbsides, can be obtained from tobacco. One method of obtaining such preparations comprises extracting tobacco with a low-boiling ketone solvent, for example acetone, successive removal from
ekstraktene av de deler som er løselige i alifatisk hydrokarbon, for eksempel heksan, og deretter et lavtkokende klorert hydrokarbon, for eksempel kloroform, og oppnåelse av en vannløselig fraksjon fra residuet, og den vandige løsning derav utsettes for behandling med ionebytte-harpikser for fjerning av basiske og sure fraksjoner, slik at man får et nøytralt residuum, hvoretter rei-duet ekstraheres med en lavere alkanol, -spesielt butanol, og løs-ningen utsettes for gelpermeabilitets- og væskekromatografi for the extracts of the parts soluble in aliphatic hydrocarbon, for example hexane, and then a low-boiling chlorinated hydrocarbon, for example chloroform, and obtaining a water-soluble fraction from the residue, and subjecting the aqueous solution thereof to treatment with ion-exchange resins to remove basic and acidic fractions, so that a neutral residue is obtained, after which the residue is extracted with a lower alkanol, -especially butanol, and the solution is subjected to gel permeability and liquid chromatography for
gjenoppløsnihg ay det i fraksjoner som er rikt på individuelle glukosider... Glukosidene i henhold til oppfinnelsen konsentreres i den sist eluerte fraksjon fra gelperraeabilitétsseparasjonen, og individuelle, rene glukosider kan isoleres ved væskékromato-grafi om så ønskes. Andre fraksjoner fra gelpermeabilitets-kromatografi inneholder glukosider av forskjellig natur, hvorav noen er béskrevet i søkerens samtidige britiske patent nr. redissolve it in fractions rich in individual glucosides... The glucosides according to the invention are concentrated in the last eluted fraction from the gel permeability separation, and individual, pure glucosides can be isolated by liquid chromatography if desired. Other fractions from gel permeability chromatography contain glucosides of various natures, some of which are described in the applicant's contemporaneous British patent no.
(Søknader 32286/75, 9989/76). Separasjonsteknikken som søkeren har anvendt, er mer spesielt beskrevet i eksemplene. (Applications 32286/75, 9989/76). The separation technique used by the applicant is more specifically described in the examples.
Ved hvert trinn i prosessen blir den tobakkaroma som . produseres ved forbrenning av fraksjonen, mer utpreget. At each step in the process, the tobacco aroma that . is produced by burning the fraction, more pronounced.
De endelige glukosider er, når de er. i ialt vesentlig ren form, farveløse, faste stoffer. De er blitt tilskrevet kjemiske strukturer ved hjelp a• v<13>C NMR (kjernemagnetisk resonans)-spektroskopi og ved enzymatisk hydrolyse til de tilsvarende aglykoner, inneholdende -OH-grupper istedenfor glukosyloksy-gruppene, og disse er blitt isolert som farve- The final glucosides are, when they are. in essentially pure form, colourless, solid substances. They have been attributed to chemical structures by a• v<13>C NMR (nuclear magnetic resonance) spectroscopy and by enzymatic hydrolysis to the corresponding aglycones, containing -OH groups instead of the glucosyloxy groups, and these have been isolated as color-
løse oljer.loose oils.
13 13
C NMR-spektroskopi og PMR (proton-magnetisk resonans)-spektroskopi er også blitt anvendt for bestemmelse av strukturen til aglykonene. C NMR spectroscopy and PMR (proton magnetic resonance) spectroscopy have also been used to determine the structure of the aglycones.
13 ' 13'
I C NMR-spektraene til substansene i henhold til oppfinnelsen produserer spirokarbonatomet (nummer 5) en karakteristisk resonans ved 50,6 - 1,0 ppm i forhold til tetrametylsilan In the C NMR spectra of the substances according to the invention, the spirocarbon atom (number 5) produces a characteristic resonance at 50.6 - 1.0 ppm relative to tetramethylsilane
(TMS)..(TMS)..
Som et ytterligere trekk som kan definere substansene 13 As a further feature that can define the substances 13
x henhold til oppfinnelsen oppviser derfor C NMR-spektraene til de nevnte substanser en karakteristisk resonans ved 50,6 1,0 ppm i forhold til tetrametylsilan. x according to the invention, the C NMR spectra of the aforementioned substances therefore exhibit a characteristic resonance at 50.6 1.0 ppm in relation to tetramethylsilane.
Glykosider i henhold til oppfinnelsen ér oppnåelige syntetisk under anvendelse.som utgangsmåterialer av et mono-eller disakkarid (spesielt glukose) og et hydroksy-mono- eller di-umettet spirovetivon. Således kan mono- eller disakkaridet være 0-acylert og omdannet til et funksjonelt derivat som er reaktivt overfor hydroksylgrupper, deretteromsatt med hydroksy-spirovetiyon-forbindelsen og O-acylgruppene i produktet hydro-lysert. Spesielt kan glukose omdannes til tetraacetoksyglukosyl-bromid som kan kondenseres med hydroksy-spirovetivonforbindelsen, og acetylgruppéne. kan hydrolyseres for frembringelse av spiro-vetivonglukosidet. Glycosides according to the invention are obtainable synthetically using as starting materials a mono- or disaccharide (especially glucose) and a hydroxy-mono- or di-unsaturated spirovetione. Thus, the mono- or disaccharide can be O-acylated and converted into a functional derivative which is reactive towards hydroxyl groups, then reacted with the hydroxy-spirovetiion compound and the O-acyl groups in the product hydrolysed. In particular, glucose can be converted to tetraacetoxyglucosyl bromide which can be condensed with the hydroxy-spirovetivon compound and the acetyl groups. can be hydrolyzed to produce the spiro-vetivone glucoside.
Foretrukne glykosider stammer fra heksoser eller pentoser, idet glukosider spesielt foretrekkes. Preferred glycosides are derived from hexoses or pentoses, glucosides being particularly preferred.
Spesifikke eksempler på de foretrukne glukosider er forbindelsene av de følgende formler t Specific examples of the preferred glucosides are the compounds of the following formulas t
hvor G representerer en Ø-D-glukosylgruppe. where G represents an Ø-D-glucosyl group.
Slike forbindelser kan eksistere i mange sterébisomerer former hvorav alle er innen oppfinnelsens ramme. Such compounds can exist in many stereobisomeric forms, all of which are within the scope of the invention.
AglykonforbihdeIsene i henhold til oppfinnelsen kan syntetiseres ved følgende prosesser: 1. En første fremgangsmåte for fremstilling av et aromagivende stoff av formelen: The aglycon compounds according to the invention can be synthesized by the following processes: 1. A first method for producing an aroma-giving substance of the formula:
omfatter å behandle enolatet av en spiranforbindeIse av formelen comprises treating the enolate of a spirin compound of the formula
med et trimetylhalogensilan for fremstilling av en trimetylsilyl- with a trimethylhalosilane to produce a trimethylsilyl-
eter, omsetning av produktet med en organisk perkarboksylsyre og hydrolyse av produktrt for fjerning av trimetylsilylgruppen fra dette. ether, reaction of the product with an organic percarboxylic acid and hydrolysis of the product to remove the trimethylsilyl group therefrom.
Én diastereoisomer med ovennevnte spiranforme1 er kjent som solavetivon. Denne forbindelse er allerede blitt isolert fra infiserte potetknoller. En blanding av fire diastereoisomerer er oppnåelig syntetisk fra Orange Oil-kondensat ved en fremgangsmåte som er beskrevet i eksemplene. One diastereoisomer with the above spiran form1 is known as solavetivon. This compound has already been isolated from infected potato tubers. A mixture of four diastereoisomers is obtainable synthetically from Orange Oil condensate by a method described in the examples.
Por utførelse av ovennevnte fremgangsmåte kan solavetivon eller den syntetiske blanding av Orange Oil-kondensat enoliseres, for eksempel ved behandling med butyl-litium i nærvær av en base (for eksempel diisopropylamin). Trimetylklorsilan, nøytralisert med en base, for eksempel trietylamin, tilsettes, By carrying out the above procedure, solavetivon or the synthetic mixture of Orange Oil condensate can be enolized, for example by treatment with butyl lithium in the presence of a base (for example diisopropylamine). Trimethylchlorosilane, neutralized with a base, for example triethylamine, is added,
for dannelse av trimetylsilylenoleteren. En løsning av denne eter i inert løsningsmiddel tilsettes ved lav temperatur (for eksempel -10°C) til en omrørt suspensjon av perkarboksylsyren (for eksempel m-klorperbenzoesyre, hvilket gir 3-trimetylsiloksy-solavetivon, som deretter kan hydrolyseres med fortynnet syre, for formation of the trimethylsilylenol ether. A solution of this ether in inert solvent is added at low temperature (eg -10°C) to a stirred suspension of the percarboxylic acid (eg m-chloroperbenzoic acid, giving 3-trimethylsiloxy-solavetivon, which can then be hydrolysed with dilute acid,
for eksempel saltsyre, og produktet kan renses på konvensjonell måte. for example hydrochloric acid, and the product can be purified in a conventional manner.
2. En annen fremgangsmåte for fremstilling av et aromagivende stoff av formelen 2. Another method for producing an aroma-giving substance of the formula
omfatter å béhandle enolatet av en forbindelse av formel comprises treating the enolate of a compound of formula
med et kompleks dannet av et molybdenperoksyd, et organisk tertiært amin og heksametylfosf or amid. with a complex formed by a molybdenum peroxide, an organic tertiary amine and hexamethylphosphor amide.
Som ved førstnevnte metode kan solavetivon, eller den syntetiske blanding av diastereoisomerer oppnådd av Orange Oil-kondensat enoliseres, for eksempel med butyl-litium. Komplekset som anvendes for å utføre oksydasjonen er kjent på området, beskrevet i Journal of.the American Chemical Society, 1974, s. 5944-5945. Por utførelse av oksydasjonen kan komplekset tilsettes i pulverform til det enoliserte solavetivon ved meget lav temperatur (for eksempel -70°c). Når reaksjonen er full-ført, kan det oljeaktige produkt ekstraheres fra blandingen og As with the former method, solavetivon, or the synthetic mixture of diastereoisomers obtained from Orange Oil condensate can be enolized, for example with butyl lithium. The complex used to carry out the oxidation is known in the art, described in the Journal of the American Chemical Society, 1974, pp. 5944-5945. To carry out the oxidation, the complex can be added in powder form to the enolized solavetivon at a very low temperature (for example -70°c). When the reaction is complete, the oily product can be extracted from the mixture and
renses på konvensjonell måte.cleaned in a conventional manner.
3. En fremgangsmåte for fremstilling av en aromasubstans av formelen 3. A method for producing an aroma substance of the formula
omfatter behandling av en forbindelse av formelen includes treatment of a compound of the formula
med osmiumtetroksyd for dannelse av en osmatester og spaltning with osmium tetroxide to form an osmate ester and cleavage
av produktet på kjent måte for spaltning av osmat-l,2-estere for derved å danne en tilsvarende 1,2-diol;. of the product in a known manner for cleavage of osmate 1,2-esters to thereby form a corresponding 1,2-diol;.
Fremgangsmåten kan utføres ved å bringe solavetivon eller den syntetiske blanding av diastereoisomerer oppnåelige fra Orange Oil-kondensat i kontakt med osmiumtetroksyd i inert The process can be carried out by contacting solavetivon or the synthetic mixture of diastereoisomers obtainable from Orange Oil condensate with osmium tetroxide in inert
miljø, for eksempel dietyleter, ved ca. 0°C. Osmatesteren kan environment, for example diethyl ether, at approx. 0°C. The osmate ester can
spaltes, for eksempel ved behandling med en vandig løsning av natriumsulfitt, og produktet kan isoleres og renses på konvensjonell måte. is decomposed, for example by treatment with an aqueous solution of sodium sulphite, and the product can be isolated and purified in a conventional manner.
Et aglykon av formelenAn aglycone of the formula
kan lages ved isomerisering av forbindelsen eller alternativt ved dehydrering av forbindelsen can be made by isomerization of the compound or alternatively by dehydration of the compound
Substansen i henhold til oppfinnelsen, spesielt glykosidene, gir en distinkt tobakkaroma til,røken fra tobakk-erstatninger som ellers ville være helt blottet for slik aroma. Bare små andeler av de rene glykosider, for eksempel 1 vékt%, er nødvendig for å gi en slik effekt. Dette er i sannhet be-merkelsesverdig, da glykosidene selv ikke er flyktige. Aglykonene som glykosidene er oppnåelige fra, gir til sammenligning bare en liten (skjønt definert) mengde av tobakkrøk-aroma til tobakkerstatninger. Aglykonene er prinsipalt nyttige som mellomprodukter som glykosidene kan fremstilles av. The substance according to the invention, especially the glycosides, gives a distinct tobacco aroma to the smoke from tobacco substitutes which would otherwise be completely devoid of such aroma. Only small proportions of the pure glycosides, for example 1% by weight, are necessary to produce such an effect. This is indeed remarkable, as the glycosides themselves are not volatile. The aglycones from which the glycosides are obtainable, by comparison, impart only a small (albeit defined) amount of tobacco smoke flavor to tobacco substitutes. The aglycones are principally useful as intermediates from which the glycosides can be prepared.
Selv om de syntetiske glykosider utgjør et spesielt trekk, inkluderes også innen oppfinnelsens ramme aromasettende substanser i form av konsentrater som er isolert fra tobakk, idet slike konsentrater for eksempel inneholder minst 25 % av de tidligere angitte glukosider. Although the synthetic glycosides constitute a special feature, aroma-setting substances in the form of concentrates isolated from tobacco are also included within the scope of the invention, as such concentrates contain, for example, at least 25% of the previously indicated glucosides.
Om ønskes, kan substansene i henhold til oppfinnelsen også bli anvendt for å forbedre eller styrke tobakkaromaen, spesielt for rekonstituert tobakk eller blandinger av tobakk og tobakk-substitutter. If desired, the substances according to the invention can also be used to improve or strengthen the tobacco aroma, especially for reconstituted tobacco or mixtures of tobacco and tobacco substitutes.
I henhold til et ytterligere trekk ved oppfinnelsen tilveiebringes derfor røkematerialer som omfatter tobakk (inklusive rekonstituert tobakk), tobakkerstatning eller en blanding av tobakk med en tobakkerstatning, og som er tilsatt en liten vektandel, for eksempel 1 %, av en substans som definert i det foregående (spesielt et glykosid). According to a further feature of the invention, smoking materials are therefore provided which comprise tobacco (including reconstituted tobacco), tobacco substitute or a mixture of tobacco with a tobacco substitute, and to which is added a small proportion by weight, for example 1%, of a substance as defined in the preceding (especially a glycoside).
Tobakk-substitutter kan for eksempel være basert på materialer av karbohydratopprinneIse, for eksempel slike materialer som er beskrevet i de britiske patentskrifter 1.055.473 og 1.143.500 samt i US-patentskrift 3.106.209, nem lig cellulose, oksydert cellulose eller salatblader. Cellulose-etere kan også anvendes. Modifiserte karbohydrater foretrekkes, idet betegnelsen "modifisert" betyr kjemisk modifisert og inne-bærer at det opprinnelige karbohydrat har gjennomgått en for-andring av kjemisk natur. Tobacco substitutes can, for example, be based on materials of carbohydrate origin, for example such materials as are described in British patents 1,055,473 and 1,143,500 as well as in US patent 3,106,209, namely cellulose, oxidized cellulose or salad leaves. Cellulose ethers can also be used. Modified carbohydrates are preferred, as the term "modified" means chemically modified and implies that the original carbohydrate has undergone a change of a chemical nature.
Tobakkerstatningen kan med fordel være et varmened-brutt karbohydrat, laget for eksempel ved å utsette karbohydrat The tobacco substitute can advantageously be a heat-degraded carbohydrate, made for example by exposing carbohydrate
(spesielt cellulose) for en katalysert nedbrytningsprosess ved en temperatur over 100°C (for eksempel 100-250°C som angitt i (especially cellulose) for a catalyzed degradation process at a temperature above 100°C (for example 100-250°C as indicated in
søkerens britiske patent 1.113.979, eller over 250°C som angitt i søkerens britiske patent 1.415.893) inntil vekten av nedbrutt karbohydrat er mindre enn 90 % av vekten av det opprinnelige karbohydrat. En lignende substans er oppnåelig som beskrevet i søkerens britiske patentskrift 1.289.354 ved syre- eller base-katalysert kondensering av en forbindelse av formelen applicant's British patent 1,113,979, or above 250°C as stated in applicant's British patent 1,415,893) until the weight of degraded carbohydrate is less than 90% of the weight of the original carbohydrate. A similar substance is obtainable as described in the applicant's British patent specification 1,289,354 by acid- or base-catalyzed condensation of a compound of the formula
hvor R 1 og R 2, som kan være like eller forskjellige, hver representerer et hydrogenatom eller en alkyl-, hydroksyalkyl-eller formyl-gruppe eller en forløper for en slik forbindelse where R 1 and R 2 , which may be the same or different, each represent a hydrogen atom or an alkyl, hydroxyalkyl or formyl group or a precursor of such a compound
(IV). (IV).
Substansene i henhold til oppfinnelsen kan innblandes i røkematerialer på enhver passende måte. Andre kjente ingredienser i røkematerialer kan inkluderes i den hensikt å gi ønskede fysikalske egenskaper og brennekarakteristika. Por eksempel kan røkematerialene inneholde gløde-regulerende katalysatorer, materialer som forbedrer aske-koherensen og farven, nikotin, andre aromastoffer, medikamenter, fuktighetsbevarende midler eller filmdannende midler. The substances according to the invention can be mixed into smoking materials in any suitable way. Other known ingredients in smoking materials can be included in order to provide desired physical properties and burning characteristics. For example, the smoking materials may contain glow-regulating catalysts, materials that improve the ash coherence and colour, nicotine, other aroma substances, drugs, humectants or film-forming agents.
Spesielt kan røkematerialene i henhold til oppfinnelsen inneholde protein, i overensstemmelse med søkerens britiske patenter 1.312.483 og 1.312.786. In particular, the smoking materials according to the invention may contain protein, in accordance with the applicant's British patents 1,312,483 and 1,312,786.
Røkematerialene i henhold til oppfinnelsen produseres gjerne i arkform, inneholdende et filmdannende middel, for eksempel en naturlig gummi eller pektin eller en celluloseeter, spesielt karboksymetylcellulose eller et salt derav. For fremstilling av slike ark kan ingrediensene i røkematerialet, for-trinnsvis sammen med tobakken eller tobakkerstatningen i fin-delt form, blandes med en tilstrekkelig mengde av vann til å produsere.en oppslemming som deretter støpes på en flate og tørkes. Arkmateriale som fremstilles av oppslemmingen, kan trevles opp slik at man får et materiale i en form som er egnet for røkning. ,; The smoking materials according to the invention are usually produced in sheet form, containing a film-forming agent, for example a natural gum or pectin or a cellulose ether, especially carboxymethyl cellulose or a salt thereof. For the production of such sheets, the ingredients of the smoking material, preferably together with the tobacco or tobacco substitute in finely divided form, can be mixed with a sufficient quantity of water to produce a slurry which is then cast on a surface and dried. Sheet material produced from the slurry can be unraveled so that a material is obtained in a form suitable for smoking. ,;
Deljforetrukne røkematerialer i henhold til oppfinnelsen er slike som er basert på tobakkerstatninger og mer spesielt på varmenedbrutte karbohydrater som tidligere definert. Slike røkematerialer i henhold til oppfinnelsen gir røk som inneholder relativt små andeler av skadelige ingredienser, og da de i seg selv har en distinkt tobakkaromå, hører det med til oppfinnelsen Partly preferred smoking materials according to the invention are those which are based on tobacco substitutes and more particularly on thermally decomposed carbohydrates as previously defined. Such smoking materials according to the invention provide smoke that contains relatively small proportions of harmful ingredients, and as they themselves have a distinct tobacco aroma, it belongs to the invention
at de kan blandes med tobakk i relativt store andeler for til-veiebringelse av blandinger som er akseptable for vanerøkere av tobakksigaretter. that they can be mixed with tobacco in relatively large proportions to provide mixtures which are acceptable to habitual smokers of tobacco cigarettes.
Oppfinnelsen skal i det følgende illustreres, men ikke begrenses av eksempler i hvilket alle deler og prosenter angir vekt. In what follows, the invention shall be illustrated, but not limited, by examples in which all parts and percentages indicate weight.
Eksempel 1Example 1
Isolasjon og karakterisering av spirovetivonglykosider fra FCV-tobakk Isolation and characterization of spirovetivine glycosides from FCV tobacco
En acetonekstrakt fra 100.000 deler røk-modnet Virginia (PCV) tobakk ble fraksjonert ved suksessiv fjerning av de deler som er løselige i heksan og deretter kloroform. Resten ble ekstrahert med vann. An acetone extract from 100,000 parts of smoke-cured Virginia (PCV) tobacco was fractionated by successively removing the parts soluble in hexane and then chloroform. The residue was extracted with water.
Den vannløselige fraksjon (4.000 deler) ble behandlet med ionebytte-harpiksår for fjerning av: (a) baser (under anvendelse av "Amberlite" IRC-50(H)/etanol) The water-soluble fraction (4,000 parts) was treated with ion-exchange resins to remove: (a) bases (using "Amberlite" IRC-50(H)/ethanol)
(b) syrer (under anvendelse av "Amberlite" IRA-45(0H)/vann)(b) acids (using "Amberlite" IRA-45(0H)/water)
og den nøytrale rest ble brakt i kontakt med n-butanol. Den butanol-løselige del (200 deler) ble utsatt for gelpermeabilitets-teknikk (under anvendelse av "Sephadex" LH 20/vann) og oppløst i fire hovedbånd. Den fraksjon som sist ble eluert (20 deler) ,. var rik på spirovetivon-glykosidene sammen med andre glykosider. Preparativ trykkvæske-kromatografi (fase - silisium-dioksyd; løsningsmiddeIsystem - dikloretan (85), acetonitril (8,5), etanol (8,5), vann (0,6)) ga oppløsning av denne fraksjon, and the neutral residue was contacted with n-butanol. The butanol-soluble fraction (200 parts) was subjected to the gel permeability technique (using "Sephadex" LH 20/water) and resolved into four major bands. The fraction which was last eluted (20 parts) ,. was rich in the spirovetivon glycosides along with other glycosides. Preparative pressure liquid chromatography (phase - silicon dioxide; solvent system - dichloroethane (85), acetonitrile (8.5), ethanol (8.5), water (0.6)) gave resolution of this fraction,
og fire spirovétivonglykosiderC^tega®^ Gl (1 del), G2 (2 deler), G3 (2 deler) og G4 (2 deler) ble isolert. Glykosidene ble oppnådd som farveløse, frysetørkede, faste stoffer. and four spirovetivone glycosides C^tega®^ Gl (1 part), G2 (2 parts), G3 (2 parts) and G4 (2 parts) were isolated. The glycosides were obtained as colorless, freeze-dried solids.
13 13
• C NMR-spektroskop! og enzymatisk hydrolyse var viktige teknikker ved karakteriseringen av disse glykosider. Glykosidene G2, G3 bg G4 ble lett hydrolyser.t av Ø-glukosidase, hvorved det ble fastslått en/3-glukosid-binding i disse materialer. De tilsvarende aglykoner som var frigjort, A2, A3bg A4, ble • C NMR spectroscope! and enzymatic hydrolysis were important techniques in the characterization of these glycosides. The glycosides G2, G3 and G4 were easily hydrolysed by Ø-glucosidase, whereby a 1/3-glucosidic bond was established in these materials. The corresponding aglycones that were released, A2, A3bg A4, were
karakterisertpå konvensjonell måte. Glykosid Gl frigjordecharacterized in a conventional way. Glycoside Gl released
ikke uten videre et aglykon under disse betingelser. Aglykon A2 ble isolert som en farveløs olje med følgende karakteristika: MS: M<+>234 (C15H2202); m/e 232, 217, 205, 176, 161, 148, not readily an aglycone under these conditions. Aglycone A2 was isolated as a colorless oil with the following characteristics: MS: M<+>234 (C15H22O2); m/e 232, 217, 205, 176, 161, 148,
133, 121, 109, 108, 91, 79, 68, 53, 41. 133, 121, 109, 108, 91, 79, 68, 53, 41.
IR (CC14): 3480, 3080, 1680, 1645, 890 cm"<1>IR (CC14): 3480, 3080, 1680, 1645, 890 cm"<1>
UV (EtOH) : ^240 nm (£= 13.800)UV (EtOH) : ^240 nm (£= 13,800)
PMR (CDC13): 1,22 (3H, d, J = 7Hz); 1,76 (3H, s); 2,03 (3H, d, PMR (CDCl 3 ): 1.22 (3H, d, J = 7Hz); 1.76 (3H, s); 2.03 (3H, d,
J = 1,5Hz); 3,82 (1H, d, J » 1-2 ,5Hz)J 4*74 (2H, utvidet); 5,83 (lH, d, J = 1,5Hz) é ppm J = 1.5Hz); 3.82 (1H, d, J » 1-2 .5Hz)J 4*74 (2H, extended); 5.83 (lH, d, J = 1.5Hz) é ppm
13 13
C NMR-data (vist i tabell 1) og PMR-lantanid-ombytting/avspaltningseksperimenter fullførte karakterisasjons-studiene , idet aglykon A2 ble identifisert som 3- hydroksy-spirovetiva- 1, ( 10), ll- dien- 2- on, hvor den sekundære metyl-gruppe i ringen og hydroksyfunksjonen er trans og diekvåtoriale. C NMR data (shown in Table 1) and PMR lanthanide exchange/cleavage experiments completed the characterization studies, identifying aglycone A2 as 3-hydroxy-spirovetiva-1, (10), 11-diene-2-one, where the secondary methyl group in the ring and the hydroxy function are trans and diequatorial.
Aglykon A3 ble isolert som en farveløs.olje med følgende karakteristika: MS: M<+>234 (C15H2202); m/e 219, 216, 206, 191, 174, 159, Aglycone A3 was isolated as a colorless oil with the following characteristics: MS: M<+>234 (C15H22O2); m/e 219, 216, 206, 191, 174, 159,
145, 137, 121, 108, 91, 79, 67, 55, 41. 145, 137, 121, 108, 91, 79, 67, 55, 41.
IR (CC14): 3620, 3450, 3080, 1676, 890 cm"<1>IR (CC14): 3620, 3450, 3080, 1676, 890 cm"<1>
UV (EtOH): A 241 nm (£ = 13.000)UV (EtOH): A 241 nm (£ = 13,000)
PMR (CDC13): 0,99 (3H, d, J = 7Hz); 1,95 (3H, d, J^v 1Hz)jPMR (CDCl 3 ): 0.99 (3H, d, J = 7Hz); 1.95 (3H, d, J^v 1Hz)j
4,14 (2H, s); 4,95 (lH, s); 5,07 (lH, s); 4.14 (2H, s); 4.95 (1H, p); 5.07 (1H, s);
5,76 (1H utvidet s) åppm5.76 (1H extended s) ppm
13 13
C NMR-data (vist i tabell 1) og PMR-lantanid-ombytting/avspaltningseksperimenter fullførte karakterisasjons-studiene. Aglykon Å3 ble således identifisert som 13- hydroksy-spirovetiva- 1 ( 10), ll- dien- 2- on. C NMR data (shown in Table 1) and PMR lanthanide exchange/cleavage experiments completed the characterization studies. Aglycone Å3 was thus identified as 13-hydroxy-spirovetiva-1 (10), 11-dien-2-one.
Aglykon A4 ble isolert som en farveløs olje med følgende karakteristika: MS: M<+>252 (<C>15<H>24<0>3); m/e 234, 222, 221, 203, 175, 161, Aglycone A4 was isolated as a colorless oil with the following characteristics: MS: M<+>252 (<C>15<H>24<0>3); m/e 234, 222, 221, 203, 175, 161,
137 (100%), 135, 133, 121, 109, 107, 95, 93, 91, 81, 79, 75, 69, 57, 43 (100%), 41. 137 (100%), 135, 133, 121, 109, 107, 95, 93, 91, 81, 79, 75, 69, 57, 43 (100%), 41.
IR (CC14): 3620, 3450, 1670 cm"<1>IR (CC14): 3620, 3450, 1670 cm"<1>
UV (EtOH): A maks. 240 nm (6 11.800)UV (EtOH): A max. 240 nm (6 11,800)
PMR (CDC13): 0,98 (3H, d, J= 7Hz)?1,25 (3H, s)* 1,97 (3H, d, PMR (CDC13): 0.98 (3H, d, J= 7Hz)?1.25 (3H, s)* 1.97 (3H, d,
J^lHz)j 3,50 (2H, q); 5,75 (1H, utvidet s) é ppm 13 J^1Hz)j 3.50 (2H, q); 5.75 (1H, extended s) é ppm 13
C NMR-data er vist i tabell 1 og bekreftet betegnelsen av aglykon A4 som 11, 12- dihvdroksy- spirovetiva- l( 10)- en- 2- on. C NMR data are shown in Table 1 and confirmed the designation of aglycone A4 as 11, 12-dihydroxy-spirovetiva-1(10)-en-2-one.
Glykosid- identifikasi onerGlycoside identifications
De tilsvarende glykosider G2, G3 og G4 ble følgelig konstitusjonelt identifisert som fl- D- qlukosidet av 3- hydroksy-spirovetiva- 1 ( 10) , ll- dien- 2- on, / 3- D- qlukosidet av 13- hydroksy-spirovetiva- 1 ( 10), ll- dien- 2- on og fl- D- qlukosidet av 11, 12-dihydroksv- spirovetiva- 1,lO-en-2-on. Tilfredsstillende spektral-data ble oppnådd for disse glukosider, og ■ 13C NMR-dataené for The corresponding glycosides G2, G3 and G4 were consequently constitutionally identified as the fl-D-qlucoside of 3-hydroxy-spirovetiva-1 (10), ll-dien-2-one, / 3-D-qlucoside of 13-hydroxy-spirovetiva - 1 (10), 11-dien-2-one and fl-D-glucoside of 11, 12-dihydroxyspirovetiva-1,10-en-2-one. Satisfactory spectral data were obtained for these glucosides, and ■ 13C NMR data for
det kjemiske ombytting for disse glukosider og også det uhydro-lyserbare glukosid Gl er vist i tabell 1/ the chemical exchange for these glucosides and also the unhydrolyzable glucoside Gl is shown in table 1/
SpektraIdatåene, spesielt<13>C NMR, av glykosid Gl var svært lik dataene for glykosid G2. Små forskjeller som ble observert (understreket i tabell 1) antydet en viss liten variasjon i struktur sentrert rundt C-3-atomet. Følgelig ble glykosid Gl konstitusjonelt identifisert som C- 3- epimeren av glukosid G2, ved det at ringmetylgruppen og glukosidbindingen i dette tilfelle har et cis-slektskapsforhold. The spectral data, especially<13>C NMR, of glycoside G1 were very similar to the data for glycoside G2. Small differences observed (underlined in Table 1) suggested some slight variation in structure centered around the C-3 atom. Accordingly, glycoside G1 was constitutionally identified as the C-3 epimer of glucoside G2, in that the ring methyl group and the glucosidic bond in this case have a cis-relationship.
Eksempel 2Example 2
Aroma- vurdering av glykosid Gl - spirovetiva- 1 ( 10), llrdien- 3-01- 2- on- j3- D-. glukosid ( epimer 1) Aroma- assessment of glycoside Gl - spirovetiva- 1 ( 10), llrdien- 3-01- 2- on- j3- D-. glucoside (epimer 1)
5,18 deler av et materiale fremstilt ved yarmenedbryt-ning av cellulose ved oppvarmning ved 250° i nærvær av 5 % ammohiumsulfamat inntil et vekttap på mer enn 10 % hadde inn-truffet, ble blandet med 60 deler vann og malt i en desintegrator. 5.18 parts of a material prepared by yarmenic decomposition of cellulose by heating at 250° in the presence of 5% ammonium sulfamate until a weight loss of more than 10% had occurred was mixed with 60 parts of water and ground in a disintegrator.
1,2 deler glycerol og 0,4 del ammoniumsulfat i 20 deler yann ble tilsatt. En tørr blanding som besto av 3,3 deler kalsiumkarbonat, 1,0 del bentonitt ble tilsatt, fulgt av 3,0 deler natriumkarboksymetylcellulose, 5,72 deler magnesitt og 0,2 del spirovetiva-1 (10) , ll-dieh-3-ol-2-on-/3-D-glukosid (epimer 1). Den resulterende oppslemming ble omrørt i minst én time og deretter støpt på en tørke som frembrakte en film med en tørrbasis-vekt på 48-52 g/m<2>. 1.2 parts glycerol and 0.4 parts ammonium sulfate in 20 parts yann were added. A dry mixture consisting of 3.3 parts calcium carbonate, 1.0 part bentonite was added, followed by 3.0 parts sodium carboxymethylcellulose, 5.72 parts magnesite and 0.2 part spirovetiva-1 (10) , ll-dieh-3 -ol-2-one-/3-D-glucoside (epimer 1). The resulting slurry was stirred for at least one hour and then cast onto a dryer which produced a film with a dry basis weight of 48-52 g/m<2>.
Filmen ble opptrevlet og trevlene forarbeidet til sigaretter og disse sigaretter ble vurdert med hensyn på aroma. En tobakkaroma ble fastslått ved røkriing av test-sigarettene. Istedenfor det/3-D-glukosid som ble anvendt i dette eksempel, kan det tilsvarende galaktosid anvendes. The film was unraveled and the fibers processed into cigarettes and these cigarettes were assessed with regard to aroma. A tobacco flavor was determined by smoking the test cigarettes. Instead of the /3-D-glucoside used in this example, the corresponding galactoside can be used.
Eksempel 3Example 3
Aroma- vurdering av glykosid G2 - spirovetiva- 1 ( 10), ll- dien- 3- ol-2- on-/ 3- D- glukosid ( epimer 2) Aroma assessment of glycoside G2 - spirovetiva- 1 ( 10), ll- diene- 3- ol-2- one-/ 3- D- glucoside ( epimer 2)
5,18 deler av et materiale fremstilt ved varmenedbryt-ning av cellulose ved oppvarmning ved 250°C i nærvær av 5 % ammoniumsulfat inntil et vekttap på mer enn 10 % hadde inn-truffet , ble blandet med 60 deler vann og malt i en desintegrator.. 1,2 deler glycerol og 6,4 del ammoniumsulfat i 20 deler vann ble tilsatt. En tørr blanding som besto av 3,3 deler kalsiumkarbonat, 1,0 del bentonitt ble tilsatt, fulgt av 3,0 deler natriumkarboksymetylcellulose, 5,72 deler magnesitt og 0,2 del spirovetiva-1 (io) , ll-dien-3-ol-2-on-/3-D-glukosid (epimer 2). Den resulterende oppslemming ble omrørt i minst en time og deretter støpt på en tørke som frembrakte en film med en tørrbasis-vekt på 48-52 g/m . 5.18 parts of a material prepared by thermal decomposition of cellulose by heating at 250°C in the presence of 5% ammonium sulfate until a weight loss of more than 10% had occurred was mixed with 60 parts of water and ground in a disintegrator .. 1.2 parts of glycerol and 6.4 parts of ammonium sulfate in 20 parts of water were added. A dry mixture consisting of 3.3 parts calcium carbonate, 1.0 part bentonite was added, followed by 3.0 parts sodium carboxymethyl cellulose, 5.72 parts magnesite and 0.2 part spirovetiva-1 (io) , ll-diene-3 -ol-2-one-/3-D-glucoside (epimer 2). The resulting slurry was stirred for at least one hour and then cast onto a drier which produced a film with a dry basis weight of 48-52 g/m 2 .
Filmen ble opptrevlet og trevlene forarbeidet til sigaretter og disse sigaretter ble vurdert med hensyn på aroma. En tobakkaroma ble fastslått ved røkning av test-sigarettene. The film was unraveled and the fibers processed into cigarettes and these cigarettes were assessed with regard to aroma. A tobacco aroma was detected when smoking the test cigarettes.
Likeledes kan en tobakkaroma erkjennes ved røkning av sigaretter laget av en blanding som ihnéholder bare natriumkarboksymetylcellulose, uorganiskfyllstoff og spirovetiva-1 (10), , ll-dien-3-ol-2-on-/3-D-glukosid (epimer 2). Likewise, a tobacco flavor can be recognized when smoking cigarettes made from a mixture containing only sodium carboxymethyl cellulose, inorganic filler and spirovetiva-1 (10), , 11-dien-3-ol-2-one-/3-D-glucoside (epimer 2) .
Eksempel 4 Example 4
Eksempel 3 ble gjentatt under anvendelse av 0,2 del av aglykonet av epimer 2 istedenfor glukosidet derav. En mindre utpreget, men erkjennelig tobakkaroma ble observert ved røkning av sigarettene. Example 3 was repeated using 0.2 part of the aglycone of epimer 2 instead of its glucoside. A less pronounced but recognizable tobacco aroma was observed when smoking the cigarettes.
Eksempel 5Example 5
Aroma- vurdering av glykosid G3 - spirovetiva- 1 ( 10), ll- dien- 13- ol-2- on-/ ?- D^- glukosid Aroma assessment of glycoside G3 - spirovetiva- 1 ( 10), ll- diene- 13- ol-2- one-/ ?- D^- glucoside
,5,18 deier av et materiale fremstilt ved varmenedbryt-ning av cellulose ved oppvarmning ved 250°C i nærvær av 5 % ammoniumsulfat inntil et vekttap på mer enn 10 % hadde inn-truffet, ble blandet med 60 deler vann og malt i én desintegrator. 1,2 deler glycerol og 0,4 del ammoniumsulfat i 20 deler vann ble tilsatt. En tørr. blanding som besto av 3,3 deler kalsiumkarbonat,. 1,0 del bentonitt ble tilsatt, fulgt av 3,0 deler natriumkarboksymetylcellulose, 5,72 deler magnesitt og 0,2 del spirovetiva-1 (10) , ll-dien-3-ol-2-on-/3-D-glukosid. Den resulterende oppslemming ,5,18 parts of a material produced by thermal decomposition of cellulose by heating at 250°C in the presence of 5% ammonium sulphate until a weight loss of more than 10% had occurred was mixed with 60 parts of water and ground in one disintegrator. 1.2 parts of glycerol and 0.4 parts of ammonium sulfate in 20 parts of water were added. A dry one. mixture which consisted of 3.3 parts calcium carbonate,. 1.0 part bentonite was added, followed by 3.0 parts sodium carboxymethyl cellulose, 5.72 parts magnesite and 0.2 part spirovetiva-1 (10) , 11-dien-3-ol-2-one-/3-D- glucoside. The resulting slurry
ble omrørt i minst en time og deretter støpt på en tørke som frembrakte én film med en tørrbasis-vekt på o 48-52 g/m was stirred for at least one hour and then cast on a dryer which produced one film with a dry basis weight of o 48-52 g/m
Filmen ble opptrevlet og trevlene forarbeidet til sigaretter og disse sigaretter ble vurdert med hensyn på aroma. En tobakkaroma ble fastslått ved røkning av test-sigarettene. The film was unraveled and the fibers processed into cigarettes and these cigarettes were assessed with regard to aroma. A tobacco aroma was detected when smoking the test cigarettes.
Eksempel 6Example 6
Eksempel 5 ble gjentatt under anvendelse av 0,2 del av spirovetiva-1 (10), ll-dien-13-ol-2-on istedenfor glukosidet derav. En mindre utpreget, men erkjennelig tobakkaroma ble observert ved røkning av sigarettene. Example 5 was repeated using 0.2 part of spirovetiva-1 (10), 11-dien-13-ol-2-one instead of its glucoside. A less pronounced but recognizable tobacco aroma was observed when smoking the cigarettes.
Eksempel 7Example 7
Aroma- vurdering av glykosid G4 - 12-( g- D- glukosyloksy)- spirovetiva-1- ( 10) -en-ll-ol-2-on ........ Aroma assessment of glycoside G4 - 12-( g- D- glucosyloxy)- spirovetiva-1-( 10)-en-ll-ol-2-one ........
5,18 deler av et materiale fremstilt ved varmenedbryt-ning av cellulose ved oppvarmning ved 250°C i nærvær av 5 % ammoniumsulfat inntil et vekttap på mer enn 10 % hadde inn- 5.18 parts of a material produced by the thermal decomposition of cellulose by heating at 250°C in the presence of 5% ammonium sulphate until a weight loss of more than 10% had taken place
truffet, ble blandet med 60 deler vann og malt i en desintegrator. 1,2 deler glycerol og 0,4 del ammoniumsulfat i 20 deler vann ble tilsatt. En tørr blanding som besto av 3,3 deler kalsiumkarbonat, 1,0 del bentonitt ble tilsatt, fulgt av 3,0 deler natriumkarboksymetylcellulose, 5,72 deler magnesitt og 0,2 del 12-(Ø-D-glukosyl-oksyJ-spirovetiva-l- (10)-en-ll-ol-2-on. Den resulterende oppslemming ble omrørt i minst én time og deretter støpt på en tørke som frembrakte en film med en tørrbasis-vekt på 48-52 g/m 2. hit, was mixed with 60 parts water and ground in a disintegrator. 1.2 parts of glycerol and 0.4 parts of ammonium sulfate in 20 parts of water were added. A dry mixture consisting of 3.3 parts calcium carbonate, 1.0 part bentonite was added, followed by 3.0 parts sodium carboxymethylcellulose, 5.72 parts magnesite and 0.2 part 12-(Ø-D-glucosyl-oxyJ-spirovetiva -1-(10)-en-ll-ol-2-one The resulting slurry was stirred for at least one hour and then cast onto a drier which produced a film with a dry basis weight of 48-52 g/m 2 .
Filmen ble opptrevlet og trevlene forarbeidet til sigaretter og disse sigaretter ble vurdert med hensyn på aroma. En tobakkaroma ble fastslått ved .røkning; av test-sigarettene. The film was unraveled and the fibers processed into cigarettes and these cigarettes were assessed with regard to aroma. A tobacco aroma was determined by smoking; of the test cigarettes.
Eksempel 8Example 8
Eksempel 7 ble gjentatt under anvendelse av 0,2 delExample 7 was repeated using 0.2 part
av spirovetiva-1-(10)-en-ll,12-diol-2-on istedenfor glukosidet derav. En mindre utpreget, men erkjennelig tobakkaroma ble observert ved røkning av sigarettene. of spirovetiva-1-(10)-en-11,12-diol-2-one instead of its glucoside. A less pronounced but recognizable tobacco aroma was observed when smoking the cigarettes.
Eksempel 9Example 9
Isolasjon og syntese av spirovetiva- 1( 10), ll- dien- 2- on ( solavetivon) Isolation and synthesis of spirovetiva-1(10),ll-dien-2-one (solavetivon)
(a) Isolasjon av solavetivon fra infiserte potetknoller(a) Isolation of solavetivon from infected potato tubers
Isoleringen av denne forbindelse fra infiserte potetknoller er beskrevet av D.T. Coxon m.fl. (Tetrahedron Letters, The isolation of this compound from infected potato tubers is described by D.T. Coxon et al. (Tetrahedron Letters,
34, 2921 (1974)). Under det her beskrevne arbeide, under anvendelse av Coxon's metoder, ga inokkuleringen av 250.000 deler poteter med soppen Phytophthora infestans, og påfølgende opp-arbeidelse, 17 deler optisk rent solavetivon. Materialet var identisk identisk i alle henseender med det som er beskrevet i 34, 2921 (1974)). In the work described here, using Coxon's methods, the inoculation of 250,000 parts of potatoes with the fungus Phytophthora infestans, and subsequent processing, gave 17 parts of optically pure solavetivon. The material was identically identical in all respects to that described in
13 13
litteraturen. En C NMR-sammenligning er vist i tabell 2 nedenunder. the literature. A C NMR comparison is shown in Table 2 below.
v v
(b) Syntese av spirovetiva- 1( 10), ll- dien- 2- on av Orange Oil-kondensat (b) Synthesis of spirovetiva-1(10),ll-dien-2-one from Orange Oil condensate
Isoleringen av (+)Valencene fra Orange Oil-kondensatThe Isolation of (+)Valences from Orange Oil Condensate
og dets omdannelse til (+)Nootkatone er beskrevet av G.L.K. Hunter og W.B. Brogdeh (Journal of Food Science 30, 876 (1965)). Om-dannelsen av (+)Nootkatone til (+)anhydro-/3-rotunol er også beskrevet '(D.S. caine og C.Chu Tetrahedron Letters, 703 (1974)). and its conversion to (+)Nootkatone is described by G.L.K. Hunter and W.B. Brogdeh (Journal of Food Science 30, 876 (1965)). The conversion of (+)Nootkatone to (+)anhydro-β-rotunol has also been described (D.S. Caine and C.Chu Tetrahedron Letters, 703 (1974)).
Disse metoder ble fulgt for å fremstille (+)anhydro-/3-rotunol,These methods were followed to prepare (+)anhydro-β-rotunol,
med spektral-egenskaper identisk dem som er beskrevet i litteraturen. with spectral properties identical to those described in the literature.
Litium/ ammoniakk- reduksjon av arihydro- ff- rotunolLithium/ ammonia reduction of arihydro- ff- rotunol
Tilnærmet 0,01 del litium ble tilsatt til 60 deler flytende ammoniakk som ble omrørt og avkjølt til -70° og var beskyttet med nitrogen. Etter 10 minutters røring begynte den blå farve, som innledningsvis ble utviklet, å blekne. Ytterligere 0,016 del litium ble tilsatt, fulgt øyeblikkelig av tilsetning av en løsning av 0,218 del (+)anhydro-0-rotunol, Approximately 0.01 part lithium was added to 60 parts liquid ammonia which was stirred and cooled to -70° and protected with nitrogen. After 10 minutes of stirring, the blue color that initially developed began to fade. Another 0.016 part of lithium was added, followed immediately by the addition of a solution of 0.218 part of (+)anhydro-O-rotunol,
0,074 del t-butanol og 10 deler dietyleter i en slik hastighet at den blå farvning ikke ble ødelagt. 1 del ammoniumklorid ble tilsatt til reaksjonsblandingen etter røring i 30 minutter ved 0.074 part t-butanol and 10 parts diethyl ether at such a rate that the blue coloration was not destroyed. 1 part of ammonium chloride was added to the reaction mixture after stirring for 30 minutes at
-70°, og blandingen ble oppvarmet til romtemperatur for fjerning av ammoniakk. Vann ble tilsatt, og den resulterende blanding -70°, and the mixture was warmed to room temperature to remove ammonia. Water was added, and the resulting mixt
ble eter-ekstrahert. Den organiske fase ble utsatt for de vanlige behandlinger med hensyn til vasking, tørking og inn-damphing og ga 0,219 del av en inndarapningsrest. som inneholdt spirovetiva-1(10), ll-dien-2-pn som hovedproduktet, sammen med et spor av anhydro-/3-rotunol. was ether extracted. The organic phase was subjected to the usual treatments of washing, drying and evaporation and yielded 0.219 part of an evaporation residue. which contained spirovetiva-1(10), 11-dien-2-pn as the major product, together with a trace of anhydro-/3-rotunol.
Det rensede produkt som ble oppnådd ved søylekromato-grafi, viste, seg ved hjelp av C NMR å være en diastereoisomer blanding av spirovetivoner som omfattet alle fire mulige The purified product obtained by column chromatography proved, by means of C NMR, to be a diastereoisomeric mixture of spirovetivones comprising all four possible
diastereoisomerer i det relative mengder Isis3:3. Som vist av dataene i tabell 2, hadde én av de mindre isomerer identiske spektral-karakteristika med naturlig forekommende solavetivon, diastereoisomers in the relative amounts of Isis3:3. As shown by the data in Table 2, one of the minor isomers had identical spectral characteristics to naturally occurring solavetivon,
hvilket ble bekreftet av spektrale "spiking" eksperimenter. which was confirmed by spectral "spiking" experiments.
Eksempel 10 Example 10
3R- og 3S- hydroksy- spirovetiva- l( 10), ll- dien- 2- oner (a) Av solavetivon via trimetylsilylenoleteren (se Rubottom m.fl.t Tetrahedron Letsters 1974, s. 4319-4322). 3R- and 3S- hydroxy- spirovetiva- l( 10), ll- diene- 2-ones (a) From solavetivon via the trimethylsilylenol ether (see Rubottom et al. Tetrahedron Letters 1974, pp. 4319-4322).
En løsning av litiumdiisopropylamid ble fremstilt ved tilsetning under nitrogen av .4,3 deler av en l,5n løsning av butyl-litium i n-heksan til en omrørt løsning av 0,61 dele diisopropylamin i 10 deler tørt THF ved -30°. Etter 10 minutters røring ved -30° ble en løsning av 1,09 deler solavetivon i 20 deler THF tilsatt, og den resulterende reaksjons-blanding ble omrørt i ytterligere 45 minutter ved -30 o til -50 o. A solution of lithium diisopropylamide was prepared by adding under nitrogen .4.3 parts of a 1.5n solution of butyllithium in n-hexane to a stirred solution of 0.61 parts of diisopropylamine in 10 parts of dry THF at -30°. After 10 minutes of stirring at -30°, a solution of 1.09 parts of solavetivon in 20 parts of THF was added, and the resulting reaction mixture was stirred for an additional 45 minutes at -30° to -50°.
Separat ble 0,922 del trimetylklorsilan tilsatt med sprøyte gjennom en serum-kappe til en løsning av 0,25 del trietylamih i 20 deler tørt THF. Det utfelte aminhydroklorid ble konsolidert ved sentrifugering, og den overstående løsning ble tilsatt til ovennevnte reaksjonsløsning ved -30°. Reaksjonsblandingen fikk varme seg til romtemperatur i løpet av 1 time. Heksan ble tilsatt til reaksjonsproduktet, og blandingen ble vasket med iskald dikarbonat-løsning, fulgt av vann, og den organiske fase ble tørket over natriumsulfat. Fjerning av løsningsmiddel etter filtrering ga 1,43 deler av et oljeaktig materiale,karakterisertsom trimetylsilylenoleteren av solavetivon. Separately, 0.922 part of trimethylchlorosilane was added by syringe through a serum jacket to a solution of 0.25 part of triethylamine in 20 parts of dry THF. The precipitated amine hydrochloride was consolidated by centrifugation, and the supernatant solution was added to the above reaction solution at -30°. The reaction mixture was allowed to warm to room temperature within 1 hour. Hexane was added to the reaction product, and the mixture was washed with ice-cold bicarbonate solution, followed by water, and the organic phase was dried over sodium sulfate. Removal of solvent after filtration gave 1.43 parts of an oily material characterized as the trimethylsilylenol ether of solavetivon.
En løsning av den rå TMS-enoleter i 20 deler n-heksan ble tilsatt til en omrørt suspensjon av 0,91 del m-klorperbenzoesyre i 40 deler n-heksan avkjølt til -10°. Etter omrøring i 1 time ved -10° ble reaksjonsblandingen filtrert og inndampet. Det rå produkt, 1,6 deler, viste seg å inneholde 3-trimetylsiloksy-solavetivon som hovedkomponent. A solution of the crude TMS enol ether in 20 parts n-hexane was added to a stirred suspension of 0.91 part m-chloroperbenzoic acid in 40 parts n-hexane cooled to -10°. After stirring for 1 hour at -10°, the reaction mixture was filtered and evaporated. The crude product, 1.6 parts, was found to contain 3-trimethylsiloxy-solavetivon as the main component.
Uten rensning ble det rå 3-trimetylsiloksy-solavétivon tatt opp i 40 deler dietyleter og omrørt kraftig med 20 deler av l,5n HCl-løsning. Etter 10 timers omrøring ble blandingen separert og det sure sjikt ekstrahert med dietyleter. De kombinerte eterekstrakter ble vasket med natriumbikarbonat-løsning, fulgt av vann, tørket over natriumsulfat og filtrert. Fjerning av løsningsmiddel ga 1,08 deler av en oljeaktig rest, som etter rensning ved hjelp av søylékromatografi over nøytral aluminiumoksyd (elueringsmidde1s 15s85, etylacetatscykloheksan) ga 0,35 del (30 % totalt) av 3-hydroksy-spirovetiva-l(10),11-dien-2-on isolert som en farveløs olje, med følgende spektral-karakteristika: MS: M<+>234 (C15H2202): m/e 219, 216, 205, 176, 161, 148, Without purification, the crude 3-trimethylsiloxy solavétivone was taken up in 40 parts of diethyl ether and stirred vigorously with 20 parts of 1.5N HCl solution. After stirring for 10 hours, the mixture was separated and the acidic layer extracted with diethyl ether. The combined ether extracts were washed with sodium bicarbonate solution, followed by water, dried over sodium sulfate and filtered. Removal of solvent gave 1.08 parts of an oily residue, which after purification by column chromatography over neutral alumina (eluent 1s 15s85, ethyl acetate cyclohexane) gave 0.35 part (30% total) of 3-hydroxy-spirovetiva-1(10) ,11-dien-2-one isolated as a colorless oil, with the following spectral characteristics: MS: M<+>234 (C15H22O2): m/e 219, 216, 205, 176, 161, 148,
133, 109, 108, 91, 79, 68, 67, 41, 39. 133, 109, 108, 91, 79, 68, 67, 41, 39.
IR (CC14): 3490, 3080, 1680, 1645, 1610, 885 cm"<1>IR (CC14): 3490, 3080, 1680, 1645, 1610, 885 cm"<1>
UV (EtOH): A240 nm ( 6 = 10.200)UV (EtOH): A240 nm ( 6 = 10,200)
PMR (CDClg): Spektret indikerte at prøven var en blanding av C-3-epimerer, hvorav In var identisk med aglykon A2, isolert etter hydrolyse fra.tobakk-fraksjoner. PMR-data vedrørende kjemisk ombytting ( & ppm fra TMS) og deres betegnelser er vist i tabell 3. PMR (CDClg): The spectrum indicated that the sample was a mixture of C-3 epimers, of which In was identical to aglycone A2, isolated after hydrolysis from tobacco fractions. Chemical shift PMR data (&ppm from TMS) and their designations are shown in Table 3.
H-spektret indikerte ogsa at forholdet mellom epimerene SA1:SA2 13 var av størrelse 1:2. C NMR-studier bekreftet dette forhold, og de tilsvarende kjemiske ombyttingsdata er vist i tabell 4 nedenunder. Det ble ikke gjort noe forsøk på å separere epimerene i dette trinn. (b) Fra solavetivon ved molybdenperoksyd- kompleksreaksjon (se Vedijs Journal bf the American Chemical Society 1974, s. 5944). The H spectrum also indicated that the ratio between the epimers SA1:SA2 13 was of the order of 1:2. C NMR studies confirmed this relationship, and the corresponding chemical shift data are shown in Table 4 below. No attempt was made to separate the epimers in this step. (b) From solavetivon by molybdenum peroxide complex reaction (see Vedijs Journal bf the American Chemical Society 1974, p. 5944).
En løsning av litiumdiisbpropylamid ble fremstilt ved tilsetning av 4,3 deler av en l,5n løsning av butyl-litium i n-heksan til 0,61 del diisopropylamin i 10 deler tørt tetrahydrofuran ved -40° omrørt under nitrogen. Etter 10 minutters røring ved -40° ble en løsning av 1,09 deler solavetivon i 20 deler tørt tetrahydrofuran tilsatt og løsningen omrørt ved -40° i 30 minutter. Etter ytterligere avkjøling til -70° ble 2,82 deler pulverisert molybdenperoksyd tilsatt (komplekset MoOg.Py.HMPAs forkortet til MoOPH ble brukt) og blandingen omrørt i 1 time ved A solution of lithium diisopropylamide was prepared by adding 4.3 parts of a 1.5N solution of butyllithium in n-hexane to 0.61 part of diisopropylamine in 10 parts of dry tetrahydrofuran at -40° under nitrogen stirring. After 10 minutes of stirring at -40°, a solution of 1.09 parts of solavetivon in 20 parts of dry tetrahydrofuran was added and the solution stirred at -40° for 30 minutes. After further cooling to -70°, 2.82 parts of powdered molybdenum peroxide were added (the complex MoOg.Py.HMPAs abbreviated to MoOPH was used) and the mixture stirred for 1 hour at
-70°. Blandingen fikk oppvarme seg til romtemperatur, vann ble tilsatt og blandingen ekstrahert med e£er. De kombinerte -70°. The mixture was allowed to warm to room temperature, water was added and the mixture was extracted with ether. They combined
ekstrakter, ble vasket med 5 % natriumkarbonat, 5 % HCl-løsning og vann, tørket og løsningsmidlet fjernet etter filtrering. extracts, were washed with 5% sodium carbonate, 5% HCl solution and water, dried and the solvent removed after filtration.
Den oljeaktige rest, 0,76 del, ble kromatografert over nøytralt aluminiumoksyd (elueringsmidde1: 15:85 etylacetat:cykloheksan) slik at man fikk 0,22 del 3-hydroksy-solavetivon (20 % utbytte). The oily residue, 0.76 parts, was chromatographed over neutral alumina (eluent 1: 15:85 ethyl acetate:cyclohexane) to give 0.22 parts of 3-hydroxy-solavetivon (20% yield).
Dette materiale oppviste de spektraie karakteristikaThis material exhibited the spectral characteristics
for produktet som ble oppnådd ved rute (a). Imidlertid indi-for the product obtained by route (a). However, indi-
13 13
kerte H- og C-dataene at forholdet mellom epimerene SAl:SA2kerte H and C data that the ratio of the epimers SAl:SA2
i dette produkt var 1:3.in this product was 1:3.
Eksempel 11Example 11
3R- og 3S-( j3- D- glukosyloksy)- spirovetiva- 1 ( 10) , ll- dien- 2- oner 3R- and 3S-(j3-D-glucosyloxy)-spirovetiva-1 (10), 11-dien-2-ones
( Syntetisk Gl og G2 - betegnet SGl og SG2)(Synthetic Gl and G2 - designated SGl and SG2)
Til en omrørt løsning av 0,47 del syntetisk 3-hydroksy-spirovetiva-l(lO), ll-dien-2-oner (SAl og SA2) i 50 deler tørt 1,2-dikloretan blerdet tilsatt 1,8 deler nylaget pulverisert sjSSlvkarbonat. Systemet ble spylt med nitrogen og oppvarmet til tilbakeløp. Reaksjonsblandingens volum ble redusert til det halve ved destillasjon, og en jodkrystall ble tilsatt. 2,25 deler 2,3,4,6-tetra-O-acetyl-a-D-glukopyranosylbromid i 300 deler 1,2-dikloretan-ble tilsatt dråpevis til den omrørte løsning i løpet av 3 timer, og i dette tidsrom fikk løsnings-midlet destillere over i en tilnærmet en hastighet. Ytterligere 200 deler 1,2-dikloretan ble tilsatt dråpevis med samtidig fjerning ved destillasjon. Reaksjonsblandingen ble filtrert og løsningsmidlet fjernet slik at man fikk 2,9 deler av en sirup-aktig rest. To a stirred solution of 0.47 part of synthetic 3-hydroxy-spirovetiva-l(lO),ll-dien-2-ones (SAl and SA2) in 50 parts of dry 1,2-dichloroethane was added 1.8 parts of freshly prepared powdered sjSSlv carbonate. The system was flushed with nitrogen and heated to reflux. The volume of the reaction mixture was reduced to half by distillation, and an iodine crystal was added. 2.25 parts of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide in 300 parts of 1,2-dichloroethane were added dropwise to the stirred solution over the course of 3 hours, and during this time the solution the agent distills over at approximately one speed. A further 200 parts of 1,2-dichloroethane were added dropwise with simultaneous removal by distillation. The reaction mixture was filtered and the solvent removed to give 2.9 parts of a syrupy residue.
Denne rest ble oppløst i 350 deler metanol og behandlet med en løsning av 2,9 deler kaliumbikarbonat i 120 deler vann. Reaksjonsblandingen ble spylt med nitrogen og fikk deretter hen-stå ved romtemperatur i 5 dager. Løsningen ble konsentrert for fjerning av metanol, og vannfasen ble ekstrahert sekvensielt med (I) eter, (II) kloroform, (III) kloroform:metanol (9:1) og (IV) kloroformmetanol (2:1). Høyhastighet-væskekromatografi påviste de ønskede glukosider i fraksjonene (II) og (III) , som etter frysetørking ga 0,13 del amorft materiale (utbytte ialt This residue was dissolved in 350 parts methanol and treated with a solution of 2.9 parts potassium bicarbonate in 120 parts water. The reaction mixture was flushed with nitrogen and then allowed to stand at room temperature for 5 days. The solution was concentrated to remove methanol, and the aqueous phase was extracted sequentially with (I) ether, (II) chloroform, (III) chloroform:methanol (9:1) and (IV) chloroformmethanol (2:1). High-speed liquid chromatography detected the desired glucosides in fractions (II) and (III), which after freeze-drying gave 0.13 parts of amorphous material (yield in total
ca. 16 %). Preparativ trykkvæske-kromatografi (fase-silisium-dioksyd: løsningsmiddelsystem - dikloretan (85), acetonitril (8,5), etanol (8,5), vann (0,6)) ga oppløsning av denne fraksjonbg glukosider, SGl, 0,04 del og SG2, 0,05 del, ble oppnådd som farveløse, frysetørkede, faste stoffer. about. 16%). Preparative pressure liquid chromatography (phase-silica-dioxide: solvent system - dichloroethane (85), acetonitrile (8.5), ethanol (8.5), water (0.6)) gave resolution of this fraction bg glucosides, SGl, 0, 04 part and SG2, 0.05 part, were obtained as colorless, freeze-dried solids.
Retensjonstidene (nemlig TMS/GC og HSLC) av SGl og SG2 var i god overensstemmelse med verdiene for de naturlig forekommende glukosider, henholdsvis Gl og G2. Tilfredsstillende • spektral-data ble også oppnådd, og C NMR-dataene for kjemisk ombytting er vist i tabell 4. The retention times (namely TMS/GC and HSLC) of SG1 and SG2 were in good agreement with the values for the naturally occurring glucosides, G1 and G2, respectively. Satisfactory • spectral data were also obtained, and the C NMR chemical shift data are shown in Table 4.
Eksempel 12Example 12
11R- og llS- 12- dihydroksy- Bpirovetiva- l( 10),- en- 2- oner11R- and 11S- 12- dihydroxy- Bpyrovetiva- 1( 10),- en- 2-ones
0,5 del osmiumtetroksyd i 25 deler dietyleter ble tilsatt til en løsning av 0,335 del solavetivon i 25 deler diety1-eter. Løsningen ble holdt ved 0° i 2 dager. Løsningsmidlet ble fjernet og 40 deler etanol tilsatt. Osmat-esteren ble spaltet ved oppvarmning på et vannbad med en løsning av natriumsulfitt (8 deler i 80 deler vann). Utfellingsproduktet ble fjernet ved filtrering og ekstrahert med varm etanol. De kombinerte fil-trater ble ekstrahert med kloroform, og den organiske fase ble vasket og tørket på vanlig måte. Fjerning av løsningsmiddel ga en oljeaktig rest, 0,32 del, som ble kromatografert over nøytralt aluminiumoksyd (elueringsmidde1: kloroform:heksan 1:1) slik at man fikk ll,12-dihydroksy-spirovetiva-l(l0),-en-2-on, 0,26 del 0.5 part osmium tetroxide in 25 parts diethyl ether was added to a solution of 0.335 part solavetivon in 25 parts diethyl ether. The solution was kept at 0° for 2 days. The solvent was removed and 40 parts ethanol added. The osmate ester was cleaved by heating on a water bath with a solution of sodium sulphite (8 parts in 80 parts water). The precipitate was removed by filtration and extracted with hot ethanol. The combined filtrates were extracted with chloroform, and the organic phase was washed and dried in the usual manner. Removal of solvent gave an oily residue, 0.32 part, which was chromatographed over neutral alumina (eluent 1: chloroform:hexane 1:1) to give 11,12-dihydroxy-spirovetiva-1(10),-en-2 -on, 0.26 part
(67 % utbytte), som en farveløs, viskøs olje. Produktet viste følgende spektrål-karakteristika: MS:M<+>2<52>(<C>1<5>H24°3)* m/e 221'161'137'107'91'(67% yield), as a colorless, viscous oil. The product showed the following spectral characteristics: MS: M<+>2<52>(<C>1<5>H24°3)* m/e 221'161'137'107'91'
84, 79, 75, 44, 43 (100 %) 41. 84, 79, 75, 44, 43 (100%) 41.
IR ("neat"): 3430, 1655, 1610, 1045 cm"<1>IR ("neat"): 3430, 1655, 1610, 1045 cm"<1>
UV (EtOH): Xmaks. 243 nm (E = 14.000)UV (EtOH): Xmax. 243 nm (E = 14,000)
PMR (CDCl3): 0,96 (3H, d, J = 7Hz), 1,17 og 1,20 (begge 3H, S, PMR (CDCl3): 0.96 (3H, d, J = 7Hz), 1.17 and 1.20 (both 3H, S,
hvilket indikérte en tilnærmet lik blanding av epiraerer): 1,95 (3H, d, J = lHz ) : 3,45 (2H, q); which indicated an approximately equal mixture of pyrites): 1.95 (3H, d, J = lHz ) : 3.45 (2H, q);
5,75 (lH, utvidet s) h ppm5.75 (lH, extended s) h ppm
<13>C NMR (CDC13) : 119,6, 167,3 og 167,5, 125,5 og. 125,6, 73,7, 69,4, <13>C NMR (CDCl3 ) : 119.6, 167.3 and 167.5, 125.5 and. 125.6, 73.7, 69.4,
50,2 og 49,9, 46,1, 42,9, 38,7.og 38,5, 36,3 og 37.0, 33,9 og 34,1, 28,3 og 27,4, 21,9 og 21,7, 21.1, 15,9 h ppm 50.2 and 49.9, 46.1, 42.9, 38.7 and 38.5, 36.3 and 37.0, 33.9 and 34.1, 28.3 and 27.4, 21.9 and 21.7, 21.1, 15.9 h ppm
Undersøkelse av relative topp-intensiteter indikerte at produktet var en tilnærmet 1:1 blanding av C-ll-epimerene, nemlig 11-R- og ll-S-12-dihydroksy-spirovetiva--l(lO) ,-en-2-oner. Examination of relative peak intensities indicated that the product was an approximately 1:1 mixture of the C-11 epimers, namely 11-R- and 11-S-12-dihydroxy-spirovetiva--1(10) ,-en-2- oners.
Eksempel 13Example 13
11R- og llS- hydroksy- 12( ff- D- glukosyloksy)- spirovetiva- 1( 10),- en-2- oner ( SG4 og epimerl 11R- and llS- hydroxy- 12( ff- D- glucosyloxy)- spirovetiva- 1( 10),- en-2-ones ( SG4 and epimerl
Til en omrørt løsning av 0,25 del syntetisk 11,12-dihydroksy-spirovetiva-1(10),-en-2-oner, i 25 deler tørt 1,2-dikloretah ble det tilsatt 0,9 del nylaget, pulverisert sølv-karbonat. Systemet ble spylt med nitrogen og oppvarmet til tilbakeløp. Reaksjonsblandingens volum ble redusert til det halve ved destillasjon, og en jodkrystall ble tilsatt. 1,13 deler 2,3,4,6-tetra-O-aeetyl-a-D-glukopyranosylbromid i 150 deler 1,2-dikloretan blé tilsatt dråpevis til den omrørte løs-ning i løpet av 3 timer, og i dette tidsrom fikk løsningsmidlet destillere over ved en tilnærmet jevn hastighet. Ytterligere 100 deler 1,2-dikloretan ble tilsatt dråpevis med samtidig fjerning ved destillasjon. Reaksjonsblandingen ble filtrert og løsningsmidlet fjernet slik at man fikk 1,3 deler av en sirup-aktig rest. To a stirred solution of 0.25 parts of synthetic 11,12-dihydroxy-spirovetiva-1(10),-en-2-ones, in 25 parts of dry 1,2-dichloroethene was added 0.9 parts of freshly prepared, powdered silver -carbonate. The system was flushed with nitrogen and heated to reflux. The volume of the reaction mixture was reduced to half by distillation, and an iodine crystal was added. 1.13 parts of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide in 150 parts of 1,2-dichloroethane was added dropwise to the stirred solution over 3 hours, during which time the solvent distill over at an approximately constant rate. A further 100 parts of 1,2-dichloroethane were added dropwise with simultaneous removal by distillation. The reaction mixture was filtered and the solvent removed to give 1.3 parts of a syrupy residue.
Denne rest ble oppløst i 175 deler metanol og behandlet med en løsning av 1,3 deler kaliumbikarbonat i 60 deler vann. Reaksjonsblandingen ble spylt med nitrogen og fikk deretter hen-stå ved romtemperatur i 5 dager. Løsningen ble konsentrert for fjerning av metanol, ogVannfasen ble ekstrahert sekvensielt med (I) eter, (II) kloroform, (III) kloroformsmetanol (9:1) og (IV) kloroformsmetanol (2:1). De ønskede glukosider ble påvist i fraksjonene (II) og (III) ved høy-hastighets-væskekromatografi. Disse fraksjoner ble kombinert og frysetørket og ga da 0,8 del ll-hydroksy-12-(Ø-D-glukosyloksy)spirovetiva-1(10),-en-2-oner (totalt utbytte ca. 19 %).<13>C NMR-data for dette materiale er vist nedenunder og bekreftet betegnelsene og indikerte nærværet av begge C-ll-epiraerer i tilnærmet like mengder. This residue was dissolved in 175 parts methanol and treated with a solution of 1.3 parts potassium bicarbonate in 60 parts water. The reaction mixture was flushed with nitrogen and then allowed to stand at room temperature for 5 days. The solution was concentrated to remove methanol, and the aqueous phase was extracted sequentially with (I) ether, (II) chloroform, (III) chloroform-methanol (9:1) and (IV) chloroform-methanol (2:1). The desired glucosides were detected in fractions (II) and (III) by high-speed liquid chromatography. These fractions were combined and freeze-dried and then gave 0.8 parts of 11-hydroxy-12-(Ø-D-glucosyloxy)spirovetiva-1(10),-en-2-ones (total yield approx. 19%).<13 >C NMR data for this material is shown below and confirmed the designations and indicated the presence of both C-II epilayers in approximately equal amounts.
<13>C NMR (Dg - DMSO): 197,8, 167,3, 124,6, 103,5, 76,8, 76,8, <13>C NMR (Dg - DMSO): 197.8, 167.3, 124.6, 103.5, 76.8, 76.8,
74,0 og 73,1, 73,6, 71,6 og 71,3, 70,1, 61,2, 49,5, 45,3, 42,7, 33,3, 26,8, 23,8 og 23,1, 20,5 og 15,6 h ppm. 74.0 and 73.1, 73.6, 71.6 and 71.3, 70.1, 61.2, 49.5, 45.3, 42.7, 33.3, 26.8, 23, 8 and 23.1, 20.5 and 15.6 h ppm.
Karbonatomene 4 og 6 ble maskert ved løsningsmiddel-resonanser. Carbon atoms 4 and 6 were masked by solvent resonances.
Claims (30)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB32288/75A GB1508617A (en) | 1975-08-01 | 1975-08-01 | Spirovetivone derivatives |
GB4745475 | 1975-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO762464L true NO762464L (en) | 1977-02-02 |
Family
ID=26261300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO762464A NO762464L (en) | 1975-08-01 | 1976-07-14 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5218836A (en) |
DD (1) | DD125670A5 (en) |
DE (1) | DE2634420A1 (en) |
ES (1) | ES450351A1 (en) |
FR (1) | FR2319616A1 (en) |
IT (1) | IT1121725B (en) |
LU (1) | LU75512A1 (en) |
NL (1) | NL7608485A (en) |
NO (1) | NO762464L (en) |
SE (1) | SE7608569L (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5973371A (en) * | 1982-10-19 | 1984-04-25 | Yamaha Motor Co Ltd | Oscillating vehicle |
US4804002A (en) * | 1987-05-29 | 1989-02-14 | P. H. Glatfelter Company | Tobacco product containing side stream smoke flavorant |
-
1976
- 1976-07-14 NO NO762464A patent/NO762464L/no unknown
- 1976-07-26 IT IT25701/76A patent/IT1121725B/en active
- 1976-07-29 SE SE7608569A patent/SE7608569L/en unknown
- 1976-07-30 LU LU75512A patent/LU75512A1/xx unknown
- 1976-07-30 DE DE19762634420 patent/DE2634420A1/en active Pending
- 1976-07-30 DD DD194152A patent/DD125670A5/xx unknown
- 1976-07-30 FR FR7623387A patent/FR2319616A1/en active Granted
- 1976-07-30 NL NL7608485A patent/NL7608485A/en unknown
- 1976-07-31 ES ES450351A patent/ES450351A1/en not_active Expired
- 1976-08-02 JP JP51092254A patent/JPS5218836A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DD125670A5 (en) | 1977-05-11 |
SE7608569L (en) | 1977-02-02 |
IT1121725B (en) | 1986-04-23 |
FR2319616A1 (en) | 1977-02-25 |
NL7608485A (en) | 1977-02-03 |
DE2634420A1 (en) | 1977-02-10 |
FR2319616B3 (en) | 1979-04-27 |
ES450351A1 (en) | 1977-11-16 |
JPS5218836A (en) | 1977-02-12 |
LU75512A1 (en) | 1977-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3874417T2 (en) | SIDE SMOKING PRODUCT CONTAINING TOBACCO. | |
US3174485A (en) | Organoleptically improved tobacco product | |
US5120368A (en) | Vanillin 5-hydroxyesters and smoking compositions containing a vanillin-release additive | |
NO762464L (en) | ||
NO762463L (en) | ||
Aasen et al. | Tobacco Chemistry. 24.(9ß)-9-Hydroxy-4-megastigmen-3-one, a new tobacco constituent | |
JP3001531B1 (en) | Tobacco flavor enhancer and tobacco products containing it | |
US4052457A (en) | 3,7,11,11-Tetramethyl-spiro-[5,5]undeca-8-ene-1-one | |
JPS5919935B2 (en) | 8.9-dihydro-8.9-dihydroxy-megastigmatrienone related compounds and tobacco flavor improvers | |
Brookes, K. Bridget*, Candy, H. Arthur** & Pegel | Atractylosides in Callilepis laureola (Asteraceae) | |
JPH099947A (en) | Tobacco aroma and flavor improver | |
EP0461872A2 (en) | Smoking compositions containing a vanillin-release beta-hydroxyester additive | |
JPS5946224A (en) | Hypotensive component obtained from rye and method for separating the same | |
Chin et al. | Natural acetylenes. Part XXXI. C 14-tetrahydropyranyl and other polyacetylenes from the compositae Dahlia coccinea Cav. var. coccinea | |
CN117736248A (en) | An ionol glycoside and its preparation method and application | |
Yoshioka et al. | Tetraneurin-E and-F. New C-15 oxygenated pseudoguaianolides from Parthenium (Compositae) | |
JPS5914472B2 (en) | (trans)-hexahydro-6-hydroxy-4,4,7a-trimethyl-2(3H)-benzofuranone and a tobacco flavor improver comprising the compound | |
Kuszmann et al. | Acetalation of 1, 6-anhydro-1 (6)-thio-D-glucitol | |
CN116162667A (en) | Synthesis method and application of 2, 4-dihydroxy-2, 5-dimethyl-3 (2H) -furanone | |
JPS5926625B2 (en) | Method for producing epimer mixture | |
CN117362212A (en) | Amino acid methyl cyclopentenolone ester type latent aromatic compound, and synthetic method and application thereof | |
JP2000102374A (en) | Tobacco flavor and taste enhancer and tobacco product containing the same | |
CN117924378A (en) | Preparation method and application of 1,4:3, 6-dianhydro-D-glucopyranose | |
CN117384116A (en) | Amino acid furanone ester type latent aromatic compound and synthetic method and application thereof | |
CN116621892A (en) | Furfuryl mercaptan glucoside derivative and chemical synthesis method and application thereof |